Clinical Trial Update: Modified Stem Cell Transplantation Procedure for Treating Chronic Granulomatous Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a modified stem cell transplantation procedure for chronic granulomatous disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatous Disease

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Chronic Granulomatous Disease | Phase 2 | Status: COMPLETED